Related references
Note: Only part of the references are listed.Benign Metastasizing Leiomyomatosis to the Skin and Lungs, Intravenous Leiomyomatosis, and Leiomyomatosis Peritonealis Disseminata: A Series of Five Cases
Joao Boavida Ferreira et al.
ONCOLOGIST (2022)
Prolonged response with bevacizumab in a patient with benign metastasizing leiomyomatosis
Shalini Chhabra et al.
GYNECOLOGIC ONCOLOGY REPORTS (2022)
The Potential of Transforming Growth Factor-beta Inhibitor and Vascular Endothelial Growth Factor Inhibitor as Therapeutic Agents for Uterine Leiomyoma
Jung Yoon Park et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2022)
Rapamycin (Sirolimus) in treatment of recurrent intravenous leiomyomatosis: a case report
G. Zhang et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2020)
Pulmonary benign metastasizing leiomyomas: a case series of 23 patients at a single facility
Rong Fan et al.
BMC PULMONARY MEDICINE (2020)
SLFN11 inhibits hepatocellular carcinoma tumorigenesis and metastasis by targeting RPS4X via mTOR pathway
Chenhao Zhou et al.
THERANOSTICS (2020)
Long-term efficacy and safety of sirolimus therapy in patients with lymphangioleiomyomatosis
Siqi Hu et al.
ORPHANET JOURNAL OF RARE DISEASES (2019)
Deep sequencing reveals the molecular pathology characteristics between primary uterine leiomyoma and pulmonary benign metastasizing leiomyoma
J. Jiang et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2018)
Recent Advances in Uterine Fibroid Etiology
Michelle M. McWilliams et al.
SEMINARS IN REPRODUCTIVE MEDICINE (2017)
Benign metastasizing leiomyoma: A review of current literature in respect to the time and type of previous gynecological surgery
Edyta Barnas et al.
PLOS ONE (2017)
Benign metastasizing leiomyoma (BML): A retrospective case series analysis of 8 patients (pts).
Vittoria Colia et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Benign Metastasizing Leiomyomas to the Lungs: An Institutional Case Series and a Review of the Recent Literature
Jordan Miller et al.
ANNALS OF THORACIC SURGERY (2016)
Benign Metastasizing Leiomyoma
Gustavo Pacheco-Rodriguez et al.
CLINICS IN CHEST MEDICINE (2016)
Hormone replacement therapy in young women with surgical primary ovarian insufficiency
Philip M. Sarrel et al.
FERTILITY AND STERILITY (2016)
Treatment decision based on the biological behavior of pulmonary benign metastasizing leiomyoma
Aurel Ottlakan et al.
JOURNAL OF THORACIC DISEASE (2016)
Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth
Arno E. Commandeur et al.
HUMAN REPRODUCTION UPDATE (2015)
Efficacy and safety of a mammalian target of rapamycin inhibitor in pediatric patients with tuberous sclerosis complex: A systematic review and meta-analysis
Guang Yang et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2015)
Rapamycin prolongs female reproductive lifespan
Li-li Luo et al.
CELL CYCLE (2013)
Rapamycin preserves the follicle pool reserve and prolongs the ovarian lifespan of female rats via modulating mTOR activation and sirtuin expression
Xing-mei Zhang et al.
GENE (2013)
Grading dermatologic adverse events of cancer treatments: The Common Terminology Criteria for Adverse Events Version 4.0
Alice P. Chen et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2012)
Comparison of Human and Rat Uterine Leiomyomata: identification of a Dysregulated Mammalian Target of Rapamycin Pathway
Judy S. Crabtree et al.
CANCER RESEARCH (2009)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Hormonal manipulation of benign metastasizing leiomyomas: Report of two cases and review of the literature
JA Rivera et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Share Paper
